Line 65: |
Line 65: |
| | | |
| ===Laboratory Tests=== | | ===Laboratory Tests=== |
| + | |
| + | Coagulation screening tests are unlikely to reveal abnormalities |
| + | until at least 36 to 72 hours post-exposure. The |
| + | prothrombin time (PT) generally becomes prolonged |
| + | first (by 36 to 48 hours), since F-VII, a component of the |
| + | tissue factor-mediated coagulation pathway, has the |
| + | shortest half-life (about six hours) and is therefore the |
| + | first factor to become depleted. The partial thromboplastin |
| + | time (PTT) and activated clotting time (ACT) are |
| + | usually prolonged by 48 to 72 hours post-exposure. The |
| + | thrombin clotting time (TCT), platelet count and buccal |
| + | mucosal bleeding time (BMBT) (an assessment of |
| + | platelet function) are usually normal (see table below). |
| + | The so-called 'proteins induced by vitamin K antagonism' |
| + | (PIVKA) are acarboxylated proteins formed as a |
| + | result of anticoagulant rodenticide toxicity. While not |
| + | normally detected in the circulation, these increase in the |
| + | plasma of poisoned animals and can be detected using |
| + | the PIVKA test which is available through some veterinary |
| + | diagnostic laboratories. PIVKA are usually cleared |
| + | within 12 hours of administration of vitamin K. Samples |
| + | for coagulation testing should be collected before initiating |
| + | vitamin K therapy. |
| + | Other possible confirmatory tests include quantitation |
| + | of vitamin K epoxide concentrations and determination |
| + | of the specific anticoagulant in the blood, liver and/or |
| + | stomach contents. |
| + | |
| ===Pathology=== | | ===Pathology=== |
| | | |